Search
Search

| 货号 | 数量 |
|---|---|
| A47013 | 16 Samples |
The Ion Torrent Oncomine Comprehensive Assay Plus GX is a targeted next-generation sequencing (NGS) assay that provides a comprehensive genomic profiling (CGP) solution appropriate for formalin-fixed paraffin-embedded (FFPE) tissues from solid tumors. The assay allows concurrent analysis of DNA and RNA to simultaneously detect a broad range of genomic alterations from 517 genes, including single-nucleotide variants (SNVs), insertions and deletions (indels), copy number variations (CNVs), and fusions. Additionally, the assay detects genomic signatures such as homologous recombination deficiency (HRD) using genomic instability metric (GIM), tumor mutational burden (TMB), and microsatellite instability (MSI).
Key features of the assay include:
When used with the Genexus Purification System and the Genexus Integrated Sequencer, sequential sample purification, library preparation, sequencing, and analysis allow for the reporting of next-day results. With just two user touchpoints and as little as 20 minutes of hands-on time, the easy, automated workflows can help reduce handling errors, free up time for your laboratory staff, and reduce labor costs. As a single vendor of sample-to-report solutions, including instruments, consumables, analysis, and support, Thermo Fisher Scientific simplifies bringing in-house CGP to your lab at varying levels of NGS expertise.